Distributional Notes on Three Wolf Spider Species (Araneae: Lycosidae) Recorded for the First Time in Diyala Province, Iraq

Posted by
  Distributional Notes on Three Wolf Spider Species (Araneae: Lycosidae) Recorded for the First Time in Diyala Province, Iraq Abstract This study presents new distributional data for three wolf spider species (Araneae: Lycosidae) from Diyala Province in eastern Iraq. Specimens were gathered from different districts and habitats between July 2025 and June 2026. The species Arctosa tbilisiensis Mcheidze, 1946, Lycosa piochardi Simon, 1876, and Wadicosa fidelis (O. Pickard-Cambridge, 1872) are recorded for the first time in Diyala, extending their known ranges within Iraq. The paper describes key diagnostic morphological features and includes information about the examined specimens and their local distributions. These findings improve knowledge of the distribution of Iraqi Lycosidae and reveal that Diyala Province, despite its habitat variety, remains insufficiently studied. The records serve as a valuable baseline for future taxonomic, faunistic, and ecological research on spiders i...

Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy

Posted by

 


Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy


Abstract

Aim

The aim of the present review is to shed light on the nanotechnological approaches adopted to overcome the shortcomings associated with the delivery of venom peptides which possess inherent anti-cancer properties.

Background

Venom peptides although have been reported to demonstrate anti-cancer effects, they suffer from several disadvantages such as in vivo instability, off-target adverse effects, limited drug loading and low bioavailability. This review presents a comprehensive compilation of different classes of nanocarriers while underscoring their advantages, disadvantages and potential to carry such peptide molecules for in vivo delivery. It also discusses various nanotechnological aspects such as methods of fabrication, analytical tools to assess these nanoparticulate formulations, modulation of nanocarrier polymer properties to enhance loading capacity, stability and improve their suitability to carry toxic peptide drugs.

Conclusion

Nanotechnological approaches bear great potential in delivering venom peptide-based molecules as anticancer agents by enhancing their bioavailability, stability, efficacy as well as offering a spatiotemporal delivery approach. However, the challenges associated with toxicity and biocompatibility of nanocarriers must be duly addressed.

Perspectives

The everlasting quest for new breakthroughs for safer delivery of venom peptides in human subjects is fuelled by unmet clinical needs in the current landscape of chemotherapy. In addition, exhaustive efforts are required in obtaining and purifying the venom peptides followed by designing and optimizing scale up technologies.


Chary, P. S., Shaikh, S., Rajana, N., Bhavana, V., & Mehra, N. K. (2024). Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy. Biomaterials Advances, 213903. https://doi.org/10.1016/j.bioadv.2024.213903